In an investor presentation in Auckland, the company said its portfolio now includes eight patented projects, 24 off-patent injectables, and several early-stage commercialisation efforts.
AFT Pharmaceuticals sees significant opportunity in a diverse R&D pipeline
July 28, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
AFT Pharmaceuticals sees significant opportunity in a diverse R&D pipeline
July 28, 2026 - - Latest News -
Long-COVID still reshaping life for medically vulnerable Australians
July 28, 2026 - - Latest News -
Australians with rare diseases still waiting too long for access to treatments
July 28, 2026 - - Latest News -
TGA approves GSK's six‑monthly treatment for severe eosinophilic asthma and nasal polyps
July 28, 2026 - - Latest News -
New research shows chronic pain is widespread and undertreated in Australia
July 28, 2026 - - Latest News -
New AI platform aims to give patients a strong voice in medicines funding
July 27, 2026 - - Latest News -
Bellberry announces new appointment to board of directors
July 27, 2026 - - Latest News

